Genomics company explores NFTs in hopes of advancing precision medicine
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Why this matters
This nft story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Pakistan explores Bitcoin mining with surplus energy, but landfill methane link remains unconfirmed
Pakistan's dual energy initiatives highlight a strategic pivot towards monetizing surplus resources, potentially reshaping its eco...
The Smarter Web Company gets shareholder go-ahead for UK’s first BTC-backed preferred stock
This innovative financial move could set a precedent for integrating cryptocurrency into traditional equity markets, influencing f...
Bitcoin Standard Treasury Company pulls plug on SPAC merger, chooses to stay private
BSTR's decision to remain private highlights the volatility and challenges in the crypto market, impacting future public listing s...
Brazilian State Energy Giant Petrobras Taps Cardano for Tracing Fuel
Brazilian state-owned energy firm Petrobras is testing Cardano’s blockchain to track the environmental benefits of renewable fuels...
Anthropic tokenized pre-IPO volume hits $643M, but liquidity test looms
Anthropic’s planned IPO could force a fast-growing crypto derivatives market to reconcile its synthetic valuation with Wall Street...
Quantum Security Startup Project Eleven Acquires Riva Labs, Adding Post-Quantum Wallet Tech
Project Eleven, a startup preparing crypto networks for the arrival of powerful quantum computers, has acquired Riva Labs, a crypt...